Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis >

Digipath Inc (DIGP)

Add DIGP Price Alert      Hide Sticky   Hide Intro
Moderator: Djdjdjdj
Search This Board: 
Last Post: 6/23/2017 11:40:29 AM - Followers: 55 - Board type: Free - Posts Today: 1

For information see:


DigiPath’s team brings over 60 years combined expertise in pioneering digital pathology, implementing over 750 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.



PathScope™ is a whole slide imaging system. PathScope™ provides high quality images in an open file format, which works with third party software packages. PathScope™ objectives can be configured with either 2, 4, 10, 20, 40, or 60x. Stage capacity options are 2, 4, or 200 slide trays.

Path Scope


PathLive™ is an affordable real time telepathology system. PathLive provides high quality images in a real time fashion and allows the remote user to remotely control objective magnifications, X & Y axis stage location, and Z axis focus plane. PathLive™ objectives can be configured with 4, 10, 20, and 40x objectives. Stage capacity is 2 slides.



Since June 2011, DigiPath has provided PathReview™, as a web viewer and image server management system for whole digital slide images. PathReview™ supports files produced by DigiPath's PathScope™, and 5 other digital pathology systems. PathReview™ includes standard annotation, measurement, and conferencing capabilities. PathReview™ works with most common web browsers, without any plug-ins required.


Since June 2011, DigiPath has provided PathConsult™, as end to end digital pathology solution to support remote consultation, 2nd opinions, and reporting capabilities. PathConsult™ provides workflows specifically for histotechnicians, pathologists, and administrators. DigiPath's PathScope™, and 5 leading digital pathology systems. PathConsults™ includes standard annotation, measurement, and conferencing capabilities. PathConsult™ works with most common web browsers, without any plug-ins required.



DigiPath’s team built telecom networks which supported over 35,000 locations throughout the country. DigiPath brings this IT experience to PathCloud™, the first and only telecom network optimized for digital pathology. PathCloud™ is an affordable, innovative, and reliable digital pathology solution networked engineered and optimized for highest digital pathology performance and reliability. PathCloud™ removes all your data storage and connectivity concerns..


PathTrade™ is the exchange initiative that provides affordable and innovative digital pathology solutions, while also providing means for underserved communities to access pathology educational and medical experts throughout the world. PathTrade™ provides existing telepathology users an affordable means to upgrade discontinued telepathology systems with a DigiPath solution.

DigiPath will provide $500 to $5,000 as a trade-in credit for upgrading to PathScope and/or PathLive. Additionally, DigiPath will refurbish the used system, and deploy system without any additional fees, in communities in need of pathology educational and medical experts. DigiPath has identified many underserved communities in Africa, India, Middle East, Southeast Asia, Caribbean, and South America, for installation in 2012.


PathStore™ is a web based e-commerce vehicle for professional serives (consultations, 2nd opinions, & quality assurance) and third party software developers to market, sell, and implement their digital pathology solutions to PathScope™ users. PathStore™ includes the ability to place third party applications on the PathScope™ desktop, or in the connected PathCloud™ network. PathStore™ will be released worldwide in 2014.


PathGuarentee™ is the digital pathology industry’s first MONEY BACK GUARANTEE program. Email for more details.

DigiPath develops and sells the affordable, innovative, and reliable digital pathology solutions for 2 nd opinion, consultation, tumor board, archiving, and educational purposes for improved workflow, analysis and data mining in support of pathology in academic medical centers, reference laboratories, biopharma organizations, and life science research institutions. Our digital pathology image-based information environment enabled by computer technology that allows for the management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed. Our digital pathology products, PathScope™, PathCloud™, PathReview™, and PathConsult™ provide a digital platform to share and store archive tissue images.

Digital Pathology Products Summary

DigiPath's digital pathology products are digital pathology solutions which employ the optical components of a standard microscope, robotic automated slide handling capabilities combined with proprietary imaging and communication software to capture high magnification images in digital format. These devices are comprised of both hardware and software.

DigiPath's digital pathology products, marketed under the names PathScope, PathCloud, PathReview, and PathConsult are used in hospital, educational pharmaceutical and research environments. Digital pathology solutions also include names of whole slide imaging and telepathology.

PathScope™ hardware

DigiPath’s PathScope is affordable, innovative, and reliable digital pathology solution. Depending on configuration, the pricing ranges from $25,000 to $75,000 capital purchase option. The options include capacity (1, 2, 3, 20, 30), objective (2.5x, 5x, 10x, 20x, 40x, 60x, 100x), barcode, and file format (JPEG, JP2k, TIFF). The reliability is based on 14 day validation period option, HIPPA, and 21CFR11 compliance.

PathCloud™ service

DigiPath's PathCloud is an affordable digital pathology solution networked engineered and optimized for digital pathology performance and reliability. PathCloud includes a USA national backbone network with 8 points of presence, 1000 TB storage, and 100M bandwidth, optimized for digital pathology. The reliability is based on PathCloud’s service level agreement which includes; 100% availability, 100% packet delivery, sub 200 milliseconds latency, and sub 1 second viewing time.

PathReview™ and PathConsult TM software

DigiPath's PathReview provides a scanner agnostic viewer and image server to review images via third party browsers, including Chrome, Internet Explorer, Firefox, and Safari. PathConsult has the features of PathReview with capability of doing a report and searchable database.

Advisory service(s)

DigiPath’s advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide. DigiPath provides advisory services for clients involved with digital pathology. Our current services range the full breadth of management operations for marketing, product development, sales outreach, operations, and customer support services. Our current clients seek our assistance in rolling out affordable, innovative, and reliable digital pathology solutions. Our potential clients include manufacturer (hardware and software), distribution and service firms, laboratories (reference, hospital owned, independent), private pathology practices (associated with hospitals), and centers of excellence.

Product Distribution

The Company sells its products either directly to end users, through exclusive distributors, non-exclusive distributors, and OEM (third party brands) depending on the application and the geographical location of the customer. Generally, qualified distributors and OEM are already in the business of selling bright field microscopes, equipment for medical analysis, or other laboratory equipment. Under the terms of the Company’s standard distribution agreements, distributors and OEM partners are assigned exclusive or non-exclusive territories or markets and, in turn, commit to purchasing a minimum amount of DigiPath products on either a quarterly or monthly basis.

Competitive Conditions

The digital pathology market is highly competitive, and many of our competitors have greater resources and better name recognition than we do. We primarily compete on affordability, innovation, and reliability. Our competitors in the digital pathology market include, Aperio, Apollo Telemedicine, D-Metrix, Hamamatsu, Nikon, Olympus, Carl Zeiss, OMNYX (owned by GE and UPMC), Leica (owned by Danaher), Phillips, Sakura, Roche, Claro, and MikroScan.

For advisory services, there are other firms providing such advisory services in the digital pathology space. There is currently an abundant need for such advisory services and we have not seen this as inhibiting our ability to garner new clients. Additionally, on larger engagements, we currently work with other advisory service firms which may be deemed as competitors. Some firms which we identified as clients may provide competitive services.


Digital pathology is the process of creating virtual slides by building digital images of physical tissue samples. Digital pathology allows drug developers, pathologists and researchers to be view tissue images through a computer or over a standard Internet connection and can be stored for later interpretation and archiving; and data mining in support of computer aided quantitative histopathology. The digital pathology markets can be categorized by type of tissue (human or animal) and use (clinical or research).

Digital pathology may improve patient care with a faster diagnosis time, more accurate diagnosis, more reproducible diagnosis, and probable lower medical costs. The improvement areas are a result of digital pathology means to provide faster turnaround time, faster access to sub-specialist, fast access to 2nd opinion, and more cost effective medical diagnosis’s.

Digital pathology is rapidly gaining momentum by reduce laboratory expenses, improve operational efficiency, enhance productivity, and improve treatment decisions and patient care. It is used worldwide in drug development, reference lab, hospital, and academic medical center settings. Applications include education, research, image analysis, archival and retrieval, laboratory information system (“LIS”) integration, secondary consultations, and virtual slide sharing. Today, education and training is the most common use for labs using digital pathology. The biggest barrier to more clinical use is the cost of scanning digital slides, which does not eliminate the need to first prepare glass slides.

Human Pathology

We estimate a total of 16,500 pathologists in the United States, with approximately two-thirds or 11,000 practicing anatomic pathology. These pathologists generally practice within one or more market segments, including hospital based pathology labs, integrated health systems, and commercial and academic research.

Pathologists focusing on human disease study the origin, course and indicators of disease. Pathology divides into clinical pathology the analysis of fluids such as urine and blood and DigiPath's market, anatomic pathology the analysis of tissue. Clinical pathology market is dominated by large national laboratories that use large-scale automation and is generally a high volume, low margin business. The technology for the automation of anatomic pathology has lagged that of clinical pathology. As a result, anatomic pathology remains a less consolidated and higher margin industry.

Animal (Veterinary) Pathology

Animal pathology includes testing in research and clinical treatment of both pets and livestock. Animal pathology for treatment is mainly conducted by labs providing services to veterinary practices. The majority of animal pathology is conducted by pharmaceutical and biotechnology companies for drug development.

The dynamics of veterinary pathology for treatment resemble human clinical pathology. Veterinary pathologists seek to improve access to clinical specialists: and aim to improve management and archiving of data workflow and tissue analysis.

The key market segments in animal pathology are pharmaceutical toxicology groups, academic and government research, contract research organizations (“CROs”), and biotechnology firms.

Digital Pathology Applications

Digital pathology products share common uses in both human and animal pathology, including consultation, communication and collaboration, education and publication, archiving and management, workflow, and analysis, as described below.

Consultation, Communication and Collaboration

Pathologists frequently consult with other pathologists and specialists in carrying out their daily work. There are often delays in consulting due to the transportation of slides or having to travel to distant locations in order to meet face-to-face. DigiPath's products allow sharing of images real time, eliminating the need for slide transportation or travel. Pathologists and specialists are able to simultaneously view and manipulate the slides and provide consultation in real-time. In addition, communication is improved as multiple pathologists and specialists can view and manipulate the same slide simultaneously.
- 4 -
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#617   #BREAKING - Nevada issues emergency regulations for approved Djdjdjdj 06/23/17 11:40:29 AM
#616   Digipaths one out of 11 marijuana labs in-Nevada..... Djdjdjdj 06/20/17 06:29:48 PM
#615   Not sure. What happened to the labs DIGP StevenRisk 06/18/17 08:46:46 PM
#614   Address won't change a thing. For the time Ciab 06/18/17 02:08:41 PM
#613   Errors found on Marijuana index about DIGP. This Djdjdjdj 06/15/17 06:43:45 PM
#612   For the time being this US Mj stock, Ciab 06/13/17 08:14:04 PM
#611   A little birdy told me that they are Djdjdjdj 06/13/17 11:57:07 AM
#610   Good press: HankyFrank 06/02/17 04:18:23 PM
#609   Thanks for clearing up that about the share Bullsonmonday 05/26/17 09:19:04 PM
#608   I certainly have issues with DIGP as well Fallingknife75 05/26/17 11:34:21 AM
#607   I've actually decided against building a position in Bullsonmonday 05/26/17 04:32:19 AM
#606   Bullsonmonday 05/26/17 02:20:10 AM
#605   There are only 3 domestic MJ companies that Bullsonmonday 05/25/17 04:29:42 AM
#604   Certainly agree, things are coming together nicely here. Fallingknife75 05/22/17 12:35:44 PM
#603   Looks like a winner to Me too. Goodbuddy4863 05/12/17 04:04:26 PM
#602   Revenue increase of over 20% from Q1. This StevenRisk 05/12/17 12:07:07 PM
#601   Digipath, Inc. Announces Second Fiscal Quarter 2017 Results Goodbuddy4863 05/12/17 09:45:36 AM
#600   Q earnings report almost due. Looking for increased StevenRisk 05/10/17 08:32:09 PM
#599   Signal Bay has a lab in Yuma City oatsuzn 04/20/17 03:21:45 PM
#598   SS can't really be compared between the two oatsuzn 04/20/17 03:20:06 PM
#597   Market Cap 7 million, otcmarkets.Com. That's very mijReswoh 04/20/17 04:40:54 AM
#596   Post #578 is key. Ideal Joint Venture deal. mijReswoh 04/20/17 04:05:09 AM
#595   Already did in Cali buddy.... Mobile lab... Southern Fivespeedchatter 04/20/17 01:21:51 AM
#594   So they only have one lab in Nevada brandao 04/20/17 12:43:25 AM
#593   There is a voice from the past :) Fallingknife75 04/19/17 09:57:15 AM
#592   Major growth coming very soon. I'm hoping the mijReswoh 04/19/17 02:23:56 AM
#591   We meet again.This is my other testing lab StevenRisk 04/18/17 10:03:51 PM
#590   Fundamentals are solid, share count although growing is Fallingknife75 04/13/17 08:50:33 PM
#589   Put on the radar. growing revenues. Super low mijReswoh 04/11/17 08:48:59 PM
#588   Looks like an insider give away---Conver PR at barknbud 03/23/17 09:20:20 AM
#587   As of the last filing yes.. General Grievous 03/19/17 11:56:22 PM
#586   Is this SS right? or needs updating?.. WallStreetSTTA 03/01/17 09:38:53 AM
#585   interesting Fibanotch 02/28/17 10:33:21 AM
#584   February 28, 2017 - 9:00 AM EST MTpennystocks 02/28/17 09:28:53 AM
#583 Cabbie_news 02/26/17 01:24:53 PM
#582   how many labs does digipath has and where thehumanchessmachine 02/26/17 09:48:02 AM
#581   An exemple: more medical marijuana growers = more MTpennystocks 02/24/17 08:30:17 AM
#580   Digipath is currently on the medical side, so MTpennystocks 02/24/17 08:14:49 AM
#578   Digipath, Inc. Enters into Joint Venture Agreement with MTpennystocks 02/22/17 05:30:10 PM
#577   MJ is a federal offense and there is Luckydog83 02/22/17 04:14:23 PM
#576   Good luck to all that held on......... Magnum7419 02/22/17 04:11:00 PM
#575   yeah this definitely broke out today. Wasn't expecting oatsuzn 02/22/17 03:06:53 PM
#574   DIGP CHART PRIMED FOR BLUE SKIES gr8investment 02/22/17 01:45:37 PM
#573   LEGIT MMJ TESTING FACILITIES DIGP! gr8investment 02/22/17 01:44:55 PM
#572   HIDDEN GEM IN DIGP! TIME TO POUNCE! gr8investment 02/22/17 01:44:31 PM
#571   DIGP GOING INTO BREAKOUT MODE gr8investment 02/22/17 01:43:49 PM
#570   Record volume today.Looks like we could be going StevenRisk 02/22/17 01:27:11 PM
#569   Came upon this from AB hope the link works Parttimetrader 02/20/17 03:36:04 PM
#568 MTpennystocks 02/16/17 12:33:31 PM
#567 MTpennystocks 02/13/17 06:30:37 PM